These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35342138)

  • 41. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of anti-SARS-CoV-2 IgG antibodies in hematologic patients with asymptomatic or mildly symptomatic COVID-19 infections].
    Hagihara M; Ohara S; Ide S; Uchida T; Inoue M; Mitamura K
    Rinsho Ketsueki; 2020; 61(10):1459-1463. PubMed ID: 33162440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors.
    Luo C; Liu M; Li Q; Zheng X; Ai W; Gong F; Fan J; Liu S; Wang X; Luo J
    Int J Infect Dis; 2021 Jul; 108():57-62. PubMed ID: 33932603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.
    Wu E; Zhang X; Zheng Y; Luo Z; Zhai W; Yin Z; Chen D; Wang Z; Zhai J; Han Y; Liu H; Li R; Wang Y; Feng Y; Shi G; Ma Y
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
    Marra A; Generali D; Zagami P; Cervoni V; Gandini S; Venturini S; Morganti S; Passerini R; Orecchia R; Curigliano G
    Ann Oncol; 2021 Jan; 32(1):113-119. PubMed ID: 33098994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 Antibody Response to Symptoms Indicative of COVID-19 in a Non-Infected Population in Japan: a Cross-Sectional Study.
    Tanaka S; Umezawa J; Yamaji T; Abe SK; Hamada A; Kobayashi O; Ushijima T; Inoue M
    Jpn J Infect Dis; 2023 Jan; 76(1):46-54. PubMed ID: 36184396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging of Hematological Patients in the Era of COVID-19.
    Eshet Y; Avigdor A; Kedmi M; Tau N
    Acta Haematol; 2022; 145(3):267-274. PubMed ID: 35100592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.
    Latifi-Pupovci H; Namani S; Pajaziti A; Ahmetaj-Shala B; Ajazaj L; Kotori A; Haxhibeqiri V; Gegaj V; Bunjaku G
    Sci Rep; 2022 Apr; 12(1):5699. PubMed ID: 35383273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of COVID-19 Infection in Healthy Subjects on Cardiac Function and Biomarkers of Oxygen Transport, Blood Coagulation and Inflammation.
    Gumanova NG; Gorshkov AU; Bogdanova NL; Korolev AI
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan.
    Nakamura S; Kanemasa Y; Atsuta Y; Fujiwara S; Tanaka M; Fukushima K; Kobayashi T; Shimoyama T; Omuro Y; Sekiya N; Imamura A
    Int J Clin Oncol; 2021 Mar; 26(3):485-493. PubMed ID: 33225396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study.
    Zivelonghi C; Dinoto A; Irani SR; McKeon A; Pilotto A; Padovani A; Masciocchi S; Magni E; Mancinelli CR; Capra R; Maniscalco GT; Volonghi I; Easton A; Alberti D; Zanusso G; Monaco S; Salvagno GL; Lippi G; Ferrari S; Mariotto S
    Immunol Res; 2023 Oct; 71(5):717-724. PubMed ID: 37171542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody glycosylation in COVID-19.
    Pongracz T; Vidarsson G; Wuhrer M
    Glycoconj J; 2022 Jun; 39(3):335-344. PubMed ID: 35091890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2-specific IgG and NCP in vulnerable patients without symptoms.
    Asti AL; Lilleri D; Zelini P; Gregorini M; Morosini M; Pattonieri EF; Grignano MA; Libetta C; Sepe V; Di Toro A; Brazzelli V; Rampino T
    New Microbiol; 2022 Jul; 45(3):213-218. PubMed ID: 35920877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The SARS-CoV-2 specific IgG antibodies biophotonic sensor.
    Szczerska M; Wityk P; Listewnik P
    J Biophotonics; 2023 Jan; 16(1):e202200172. PubMed ID: 36222282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19.
    Harte JV; Coleman-Vaughan C; Crowley MP; Mykytiv V
    Crit Rev Clin Lab Sci; 2023 Dec; 60(8):595-624. PubMed ID: 37439130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the positivity rate of anti-spike and anti-nucleocapsid SARS-CoV-2 IgG in asymptomatic pregnant women.
    Heireman L; Baetens M; Menten B; Dehaene I; Padalko E
    J Obstet Gynaecol; 2022 Jul; 42(5):1541-1542. PubMed ID: 34958623
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to the Letter to the Editor Regarding "Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021".
    Sanada T; Kohara M
    J Epidemiol; 2023 Feb; 33(2):109. PubMed ID: 35908936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.